November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
November 13, 2025 - 05:35
New Research Hub Explores Technology's Influence on DemocracyThe Rutgers Democracy Lab (RDL) at the Eagleton Institute of Politics has officially inaugurated the Technology and Democracy Research Hub. This initiative aims to investigate the intricate...
November 12, 2025 - 18:04
Enhanced Printing Solutions Through New PartnershipThe Department of Information Technology has officially entered into a strategic partnership with Xerox Corporation, a leader in innovative printing services and solutions. This collaboration aims...
November 12, 2025 - 08:14
Cloud Native Infrastructure Becomes Essential for AI and ML PractitionersThe latest CNCF Tech Radar report highlights a significant shift in the landscape of artificial intelligence (AI) and machine learning (ML). It emphasizes that cloud native infrastructure has...
November 11, 2025 - 21:11
Big Rapids Township Report Finds No Threats in Mackinac Technology PlanIn a recent assessment, Big Rapids Township officials have concluded that there are no significant concerns regarding Mackinac Technology`s proposed initiatives. The due diligence process involved...